Michael E. Lachman
Michael Lachman brings 30 years of experience in medical technology, including consulting, investment research, business development, marketing, and engineering. His active involvement in the ophthalmology sector spans over 20 years.
Before launching EyeQ Research in 2005, Michael was a Partner, Managing Director, and equity research analyst with ThinkEquity Partners, a growth-focused investment bank based in San Francisco. At ThinkEquity, Michael's research was focused primarily on ophthalmic devices and pharmaceuticals, orthopedics, and specialty cardiology. Before that, Michael was a healthcare analyst on the buy-side with SAC Capital Advisors and Jurika & Voyles. His first experience in equity research was as a medical device analyst with Hambrecht & Quist, where he received a #1 ranking in medical industry stock picking in the Wall Street Journal All-Star Analyst Survey.
As a sell-side research analyst, Michael covered a broad range of eye care companies:
Diversified Eye Care: Alcon, Advanced Medical Optics, Bausch + Lomb
Refractive Surgery: VISX, Summit Autonomous, IntraLase, TLC Vision
Retina: QLT, Eyetech Pharmaceuticals, OccuLogix
Vision Care: Ocular Sciences
Michael also brings 12 years of medical device industry experience. He worked for five years in business development for the Ethicon Endo-Surgery division of Johnson & Johnson. Previously, Michael spent seven years with Baxter Healthcare Corporation, working in both research & development and product management, with a focus on implantable surgical products.
Michael holds an M.B.A. (with concentrations in marketing and finance) from Northwestern University's Kellogg School of Management. He also holds an M.S. in Mechanical Engineering from Stanford University. Michael received a B.S. in Aeronautical Engineering with highest honors from the University of Illinois.
We are affiliated with organizations that promote excellence, innovation, and high standards in the fields in which we work.
AECOS brings together leading ophthalmologists and innovators in order to advance vision care and improve patients’ quality of life. Michael Lachman was an invited faculty member at the 2013 and 2014 AECOS Deer Valley Summer Symposia, speaking on the topic of trends in the premium ophthalmic surgical practice. www.aecosurgery.org
The Qualitative Research Consultants Association (QRCA) is a not-for-profit association of consultants involved in the design and implementation of qualitative research. QRCA is dedicated to promoting excellence in the field, believing strongly that its members must uphold the highest standards of ethical and professional behavior, not only in their work, but in their relationships with clients, suppliers, colleagues and respondents. www.qrca.org
The Ophthalmology Innovation Summit (OIS) unites a diverse group of key players in ophthalmology, creating an ecosystem of clinical, technology, and business professionals to drive and foster ophthalmic innovation. www.ois.net
ESCRS was founded in 1991 to promote education and research in the field of implant and refractive surgery and to advance and promote the study and practice of ophthalmology. www.escrs.org
We support the bold vision of The Cure is in Sight: The Campaign for Glaucoma Research Foundation. GRF is a national non-profit organization dedicated to finding a cure for glaucoma by investing in innovative research, education, and support. www.glaucoma.org
Michael Lachman was an invited faculty member at the Presbyopia 2014 Symposium in London, at Presbyopia 2015 in Barcelona, at Presbyopia 2016 in Copenhagen, and at Presbyopia 2018 in Vienna, speaking on the topic of the global surgical presbyopia market opportunity.